Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of FDG PET imaging for expanding patient eligibility and measuring treatment response in a genome-driven basket trial of the Pan-HER kinase inhibitor, neratinib
    Journal Article

    Ulaner, G. A.; Saura, C.; Piha-Paul, S. A.; Mayer, I.; Quinn, D.; Jhaveri, K.; Stone, B.; Shahin, S.; Mann, G.; Dujka, M.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Response to anti-EGFR therapy in patients with BRAF non-V600–mutant metastatic colorectal cancer
    Journal Article

    Yaeger, R.; Kotani, D.; Mondaca, S.; Parikh, A. R.; Bando, H.; Van Seventer, E. E.; Taniguchi, H.; Zhao, H.; Thant, C. N.; de Stanchina, E.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • A clinical utility study of plasma DNA next generation sequencing guided treatment of uncommon drivers in advanced non-small-cell lung cancers
    Meeting Abstract

    Tu, H.; Xu, C.; Tong-Li, C.; Offin, M.; Razavi, P.; Schapira, E.; Namakydoust, A.; Lee, A.; Pavlakis, N.; Clarke, S.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Integrated germline and somatic analysis identifies actionable cancer predisposing germline mutations in 9,734 patients with advanced cancers
    Meeting Abstract

    Jayakumaran, G.; Mandelker, D.; Birsoy, O.; Jairam, S.; Li, Y.; Yang, C.; Somar, J.; Rai, V.; Syed, A.; Benayed, R.; more...
    Journal of Molecular Diagnostics (2019)

    Fulltext@MSK | Save
  • Germline RAD51B loss-of-function variants confer susceptibility to hereditary breast and ovarian cancers and result in homologous recombination deficient tumors
    Meeting Abstract

    Mandelker, D.; Mukherjee, S.; Setton, J.; Cadoo, K.; Selenica, P.; Kemel, Y.; Ceyhan-Birsoy, O.; Sheehan, M.; Tkachuk, K.; Brown, D.; more...
    Journal of Molecular Diagnostics (2019)

    Fulltext@MSK | Save
  • T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers
    Meeting Abstract

    Ma, J.; Klatt, M.; Dundar, F.; Zumbo, P.; Femia, M.; Betel, D.; Scheinberg, D.; Baker, B.; Klebanoff, C.; Chandran, S.
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Feasibility of an outpatient 12-step desensitization for patients with history of carboplatin hypersensitivity reactions (HSR) undergoing retreatment with carboplatin for recurrent ovarian or endometrial cancer
    Meeting Abstract

    LaVigne, K.; Eroglu, I.; Mainardi, T.; Sabbatini, P.; Sklarin, N.; O'Cearbhaill, R.
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save
  • Analysis of BRCA genes and homologous recombination deficiency (HRD) scores in tumours from patients (pts) with metastatic breast cancer (mBC) in the OlympiAD trial
    Meeting Abstract

    Robson, M.; Lai, Z.; Dearden, S.; Barrett, J. C.; Harrington, E. A.; Timms, K.; Lanchbury, J.; Wu, W.; Allen, A.; Goessl, C.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Prospective study evaluating white adipose tissue inflammation and clinicopathologic features in endometrial cancer
    Meeting Abstract

    Moukarzel, L. A.; Stylianou, A.; Wu, M.; Nobre, S. P.; Abu-Rustum, N. R.; Broach, V.; Giri, D. D.; Iyengar, N. M.; Weigelt, B.; Makker, V.
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • A randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard care in women with residual, early stage/resectable, triple negative breast cancer after standard-of-care neoadjuvant chemotherapy
    Meeting Abstract

    McArthur, H. L.; Comen, E. A.; Bryce, Y.; Solomon, S. B.; Leal, J. H. S.; Rodine, M.; Abaya, C. D.; Patil, S.; Page, D. B.; Norton, L.
    Annals of Oncology (2019)

    Fulltext@MSK | Save